SCHEMBL12960080

SCHEMBL12960080

c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc(N(c4ccccc4)c4ccc5sc6ccccc6c5c4)cc3)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.42
▸ CYP1A2 P05177 2/20 0.38
▸ MAPT P10636 4/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ HPGD P15428 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ PTPN7 P35236 1/20 0.36
▸ DUSP3 P51452 1/20 0.36
▸ PTPN12 Q05209 1/20 0.36
▸ PTPN22 Q9Y2R2 1/20 0.36
▸ APP P05067 1/20 0.35
▸ TNKS O95271 1/20 0.35
▸ TNKS2 Q9H2K2 1/20 0.35
▸ PIM3 Q86V86 1/20 0.35
▸ PTGIR P43119 1/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ TDP1 Q9NUW8 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14295386 1.00 GPR3 (0.42) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL12960070 0.98 GPR3 (0.44) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL12960038 0.98 GPR3 (0.44) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL12960076 0.98 GPR3 (0.44) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL17465354 0.98 GPR3 (0.44) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL23172153 0.97 GPR3 (0.45) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL12414481 0.97 GPR3 (0.45) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL15306322 0.97 GPR3 (0.45) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL21425305 0.97 GPR3 (0.45) GPR3CYP1A2MAPTALDH1A1HPGD
SCHEMBL12414492 0.97 GPR3 (0.45) GPR3CYP1A2MAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9278926-B2 Aromatic amine derivative, and organic electroluminescent element comprising same IDEMITSU KOSAN CO., LTD. (JP) 2016-03-08 — — US disclosed
US-9278926-B2 Aromatic amine derivative, and organic electroluminescent element comprising same IDEMITSU KOSAN CO., LTD. (JP) 2016-03-08 — — US disclosed
US-20120248426-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-10-04 — — US disclosed
US-20120248426-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-10-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120248426-A1 AROMATIC AMINE DERIVATIVE, AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME AOC2, AHR, AOC3 GPR3 1614/4885CYP1A2 335/4885MAPT 2264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback